Author:
Razmaria Ali Aria,Schoder Heiko,Morris Michael J.
Publisher
Springer International Publishing
Reference132 articles.
1. Czernin J, Satyamurthy N, Schiepers C. Molecular mechanisms of bone 18F-NaF deposition. J Nucl Med. 2010;51(12):1826–9.
2. Grant FD, Fahey FH, Packard AB, Davis RT, Alavi A, Treves ST. Skeletal PET with 18F-fluoride: applying new technology to an old tracer. J Nucl Med. 2008;49(1):68–78.
3. Mick CG, James T, Hill JD, Williams P, Perry M. Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease. AJR Am J Roentgenol. 2014;203(2):263–71.
4. Centers For Medicare & Medicaid Services. Decision Memo for Positron Emission Tomography (NaF-18) to Identify Bone Metastasis of Cancer (CAG-00065R2); 2015. Available from: https://www.cms.gov/medicare-coverage-database/details/nca-decision-memo.aspx?NCAId=279.
5. American College Of Radiology. CMS Refuses Medicare Coverage of NaF PET Scans 2018.